Send E-mail
Send SMS
SWASTIK LIFESCIENCES
SWASTIK LIFESCIENCES
Industrial Area Phase 2, Panchkula, Haryana
Send E-mail
Send SMS
Home »

About Us


Company Factsheet

Basic Information
IndiaMART TrustSeal
Nature of Business
Manufacturer
Total Number of Employees
Upto 10 People
Year of Establishment
2015
Legal Status of Firm
Sole Proprietorship (Individual)
Annual Turnover
Rs. 5 - 10 Crore
GST No.
06ACYPJ3904G1ZF


Why Us?

Why Us?

Click to Zoom

Established in the year 2015, "SwisskeM Healthcare ", has very swiftly attained a top reputation in India’s burgeoning pharmaceutical market for providing Franchise on a quality range of Pharmaceutical Products. With Franchises set up in over 20 Indian States, our drugs have been highly recommended by the country’s best doctors, clinics and hospitals. As an honest organisation, we ensure that our drugs are processed with supreme quality ingredients. Moreover, our Quality Experts utilise high-tech testing techniques to check quality parameters of the drugs. We adhere to the Regulations & Guidelines laid out by the Indian Pharmaceutical Association. We also guarantee our customers that our drugs don’t cause any side effects.

As an organisation, we pride ourselves on the quality of our products – which have earned the trust of India’s topmost doctors. To fulfil our commitments, we have set up an ultramodern infrastructural facility that is equipped with latest technology and machinery. Our facility is a pollution-free zone since we use oil-free compressor for production purposes. To keep pace with global standards, we are constantly looking to make technological upgrades and enhancements. We have promised to work with only qualified chemists and pharmaceutical vendors who have been shortlisted on the basis of their credibility and past track record.



 



Company Profile
Why Us?




Corporate Brochure




 

 

Send SMS
SWASTIK LIFESCIENCES
Vaneet Jain  (Managing Director)
Plot No-295, Phase-2 Industrial Area
Industrial Area Phase 2, Panchkula - 134113 , Haryana , India
Send E-mail
Share Us: